Table of Contents
Survey: HR Leaders Challenged with Employee Mental Health Needs
Uprise Health research provides new ways for benefits brokers to…
Learn More
Understanding the Connection: Mental Health’s Impact on Physical Health
In the intricate balance of well-being, the relationship between mental…
Learn More
Preventative Care: Take Control of Your Health
In the hustle and bustle of our daily lives, health…
Learn MoreJared Beaumont, M.P.H.1, Theresa Cassidy, M.P.H.1, Taryn Dailey Govoni, M.P.H.1
Presented at International Conference on Opioids 2017
“Abuse and route of administration prevalence for tapentadol products within the NAVIPPRO® ASI-MV® surveillance system”
Post-market surveillance data indicate low abuse levels of tapentadol products, but research regarding the route of administration profile of tapentadol abusers is limited. Our analyses evaluated abuse and routes of administration of tapentadol within a sample of 270,695 adults assessed for substance abuse problems during January 2012 through September 2016.